Johnson & Johnson (NYSE: JNJ) today announced new long-term data from the QUASAR long-term extension (LTE) study showing that TREMFYA® (guselkumab) sustained clinical, endoscopic, and histologic ...

"Due to the timing of diagnosis during this critical period of physical, intellectual, and psychosocial development, the higher rate of colectomy, and their longer lifespan without a colon, it is ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...

Greater access to innovative treatments could be linked to a drop in patients requiring surgery for a type of inflammatory bowel disease, a 20-year study suggests. The number of patients using ...

The risk for colectomy declined over the past two decades among Finnish patients with newly diagnosed ulcerative colitis (UC), particularly between 2013 and 2020, when several advanced treatment ...

What Is Infusion for Ulcerative Colitis? If your doctor has recommended infusion therapy, this is probably because standard treatment hasn’t helped relieve symptoms caused by moderate-to-severe ...

Crohn’s and UC affect the GI tract differently. Crohn’s impacts the whole tract, while UC is limited to the colon. Learn the ...

NEW YORK A new study led by Mayo Clinic researchers found that ulcerative colitis patients had a 41% reduction in colectomy when treated with infliximab for one year, according to a study published in ...